Literature DB >> 33322614

Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction.

Emelie Lassén1, Ilse S Daehn1.   

Abstract

Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD), with prevalence increasing at an alarming rate worldwide and today, there are no known cures. The pathogenesis of DKD is complex, influenced by genetics and the environment. However, the underlying molecular mechanisms that contribute to DKD risk in about one-third of diabetics are still poorly understood. The early stage of DKD is characterized by glomerular hyperfiltration, hypertrophy, podocyte injury and depletion. Recent evidence of glomerular endothelial cell injury at the early stage of DKD has been suggested to be critical in the pathological process and has highlighted the importance of glomerular intercellular crosstalk. A potential mechanism may include reactive oxygen species (ROS), which play a direct role in diabetes and its complications. In this review, we discuss different cellular sources of ROS in diabetes and a new emerging paradigm of endothelial cell dysfunction as a key event in the pathogenesis of DKD.

Entities:  

Keywords:  ROS; diabetic kidney disease; glomerular endothelial cells

Year:  2020        PMID: 33322614      PMCID: PMC7764016          DOI: 10.3390/ijms21249456

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  165 in total

Review 1.  Life's smile, death's grin: vital functions of apoptosis-executing proteins.

Authors:  Carmen Garrido; Guido Kroemer
Journal:  Curr Opin Cell Biol       Date:  2004-12       Impact factor: 8.382

2.  SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE.

Authors:  Xiaoxin X Wang; Jonathan Levi; Yuhuan Luo; Komuraiah Myakala; Michal Herman-Edelstein; Liru Qiu; Dong Wang; Yingqiong Peng; Almut Grenz; Scott Lucia; Evgenia Dobrinskikh; Vivette D D'Agati; Hermann Koepsell; Jeffrey B Kopp; Avi Z Rosenberg; Moshe Levi
Journal:  J Biol Chem       Date:  2017-02-14       Impact factor: 5.157

Review 3.  Mitochondrial disorders and the kidney.

Authors:  P Niaudet
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

4.  Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.

Authors:  Nicole Stieger; Kirstin Worthmann; Beina Teng; Stefan Engeli; Anibh M Das; Hermann Haller; Mario Schiffer
Journal:  Metabolism       Date:  2012-02-24       Impact factor: 8.694

5.  Hyperuricemia induces endothelial dysfunction via mitochondrial Na+/Ca2+ exchanger-mediated mitochondrial calcium overload.

Authors:  Quan Hong; Ka Qi; Zhe Feng; Zhiyong Huang; Shaoyuan Cui; Liyuan Wang; Bo Fu; Rui Ding; Jurong Yang; Xiangmei Chen; Di Wu
Journal:  Cell Calcium       Date:  2012-02-22       Impact factor: 6.817

6.  A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency.

Authors:  Catarina Quinzii; Ali Naini; Leonardo Salviati; Eva Trevisson; Placido Navas; Salvatore Dimauro; Michio Hirano
Journal:  Am J Hum Genet       Date:  2005-12-22       Impact factor: 11.025

7.  Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction.

Authors:  Abdulrahman K Doughan; David G Harrison; Sergey I Dikalov
Journal:  Circ Res       Date:  2007-12-20       Impact factor: 17.367

8.  Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high-fat diet.

Authors:  Susumu Takagi; Jinpeng Li; Yuta Takagaki; Munehiro Kitada; Kyoko Nitta; Toshiyuki Takasu; Keizo Kanasaki; Daisuke Koya
Journal:  J Diabetes Investig       Date:  2018-03-12       Impact factor: 4.232

9.  Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.

Authors:  Assaad A Eid; Yves Gorin; Bridget M Fagg; Rita Maalouf; Jeffrey L Barnes; Karen Block; Hanna E Abboud
Journal:  Diabetes       Date:  2009-02-10       Impact factor: 9.461

10.  ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.

Authors:  Shazia Ashraf; Heon Yung Gee; Stephanie Woerner; Letian X Xie; Virginia Vega-Warner; Svjetlana Lovric; Humphrey Fang; Xuewen Song; Daniel C Cattran; Carmen Avila-Casado; Andrew D Paterson; Patrick Nitschké; Christine Bole-Feysot; Pierre Cochat; Julian Esteve-Rudd; Birgit Haberberger; Susan J Allen; Weibin Zhou; Rannar Airik; Edgar A Otto; Moumita Barua; Mohamed H Al-Hamed; Jameela A Kari; Jonathan Evans; Agnieszka Bierzynska; Moin A Saleem; Detlef Böckenhauer; Robert Kleta; Sherif El Desoky; Duygu O Hacihamdioglu; Faysal Gok; Joseph Washburn; Roger C Wiggins; Murim Choi; Richard P Lifton; Shawn Levy; Zhe Han; Leonardo Salviati; Holger Prokisch; David S Williams; Martin Pollak; Catherine F Clarke; York Pei; Corinne Antignac; Friedhelm Hildebrandt
Journal:  J Clin Invest       Date:  2013-11-25       Impact factor: 14.808

View more
  11 in total

Review 1.  Cellular crosstalk of glomerular endothelial cells and podocytes in diabetic kidney disease.

Authors:  Shan Jiang; Manyu Luo; Xue Bai; Ping Nie; Yuexin Zhu; Hangxi Cai; Bing Li; Ping Luo
Journal:  J Cell Commun Signal       Date:  2022-01-18       Impact factor: 5.908

2.  Sitagliptin protects renal glomerular endothelial cells against high glucose-induced dysfunction and injury.

Authors:  Liang Xu; Fengmin Shao
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

Review 3.  Recent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis.

Authors:  Peir-Haur Hung; Yung-Chien Hsu; Tsung-Hsien Chen; Chun-Liang Lin
Journal:  Int J Mol Sci       Date:  2021-11-01       Impact factor: 5.923

Review 4.  The Pathogenesis of End-Stage Renal Disease from the Standpoint of the Theory of General Pathological Processes of Inflammation.

Authors:  Evgenii Gusev; Liliya Solomatina; Yulia Zhuravleva; Alexey Sarapultsev
Journal:  Int J Mol Sci       Date:  2021-10-23       Impact factor: 5.923

Review 5.  Long Non-Coding RNAs in the Pathogenesis of Diabetic Kidney Disease.

Authors:  Mengsi Hu; Qiqi Ma; Bing Liu; Qianhui Wang; Tingwei Zhang; Tongtong Huang; Zhimei Lv
Journal:  Front Cell Dev Biol       Date:  2022-04-20

6.  Glucagon-Like Peptide 1 Receptor Agonist Improves Renal Tubular Damage in Mice with Diabetic Kidney Disease.

Authors:  Ran Li; Dunmin She; Zhengqin Ye; Ping Fang; Guannan Zong; Yong Zhao; Kerong Hu; Liya Zhang; Sha Lei; Keqin Zhang; Ying Xue
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-29       Impact factor: 3.249

7.  KITLG Promotes Glomerular Endothelial Cell Injury in Diabetic Nephropathy by an Autocrine Effect.

Authors:  Jiun-Chi Huang; Szu-Chia Chen; Wei-An Chang; Wei-Wen Hung; Ping-Hsun Wu; Ling-Yu Wu; Jer-Ming Chang; Ya-Ling Hsu; Yi-Chun Tsai
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208

Review 8.  The glomerular filtration barrier: a structural target for novel kidney therapies.

Authors:  Ilse S Daehn; Jeremy S Duffield
Journal:  Nat Rev Drug Discov       Date:  2021-07-14       Impact factor: 84.694

Review 9.  Modeling the Glomerular Filtration Barrier and Intercellular Crosstalk.

Authors:  Kerstin Ebefors; Emelie Lassén; Nanditha Anandakrishnan; Evren U Azeloglu; Ilse S Daehn
Journal:  Front Physiol       Date:  2021-06-02       Impact factor: 4.755

10.  Integrative Role of Albumin: Evolutionary, Biochemical and Pathophysiological Aspects.

Authors:  D A Belinskaia; P A Voronina; N V Goncharov
Journal:  J Evol Biochem Physiol       Date:  2021-12-20       Impact factor: 0.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.